Published independent advice on use of GnRH agonists

Chris Northwood made this Freedom of Information request to Commission on Human Medicines Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

The request was refused by Commission on Human Medicines.

Dear Commission on Human Medicines,

Please can you provide under the Freedom of Information Act a copy of the independent advice used to advise Wes Streeting and the Department of Health and Social Care about the use of GnRH agonist (so-called "puberty blockers") on the risks of such, and the correspondance between contributors that was used in the development of this advice?

Yours faithfully,

Cllr Chris Northwood

MHRA Customer Services, Commission on Human Medicines

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Experience
Centre Team. We will respond to you as soon as possible.

 

Please note that we may not respond if your query:

·         contains offensive language

·         has already been answered in a previous reply to you

·         is illegible

·         is selling or promoting a product

·         is for information only

 

Kind regards

MHRA Customer Experience Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

DISCLAIMER This email and any files transmitted with it are confidential.
If you are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this email is
prohibited and may be unlawful. If you are not the intended recipient,
please notify the sender immediately by using the reply function and then
permanently delete what you have received. Incoming and outgoing email
messages are routinely monitored for compliance with the Department of
Health's policy on the use of electronic communications. For more
information on the Department of Health's email policy, click
[1]DHTermsAndConditions

References

Visible links
1. file:///tmp/%20https:/www.gov.uk/help/terms-conditions

FOI Team, Commission on Human Medicines

MHRA reference: FOI2024/00786

Dear Chris Northwood,

Thank you for your information request, which we received on 11 December.
We have understood your request to be for the following information:

Please can you provide under the Freedom of Information Act a copy of the
independent advice used to advise Wes Streeting and the Department of
Health and Social Care about the use of GnRH agonist (so-called "puberty
blockers") on the risks of such, and the correspondance between
contributors that was used in the development of this advice?

If we have misunderstood or misinterpreted your request, please contact us
as soon as possible.

We will deal with your request under the Freedom of Information Act 2000
(FOIA). The statutory time frame for response is 20 working days; this
begins on the first working day after receipt, and we will respond by 14th
January.

If you need to contact us about this request, please quote the reference
number above.

We publish our responses to FOI requests with requester details removed.
You can view these on our website here:

[1]Transparency and freedom of information releases - GOV.UK (www.gov.uk)

Yours sincerely

Healthcare, Quality and Access Group

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 020 3080 6000

[2]gov.uk/mhra

[3]Stay connected

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: [4]MHRA,
[5]CPRD and [6]NIBSC.

Appeal rights

If you are dissatisfied with the handling of your request, you have the
right to ask for an internal review. Internal review requests should be
submitted within two months of the date you receive this response and
addressed to: [email address]

If you remain dissatisfied with the outcome of the internal review, you
have the right to apply directly to the Information Commissioner for a
decision. Please bear in mind that the Information Commissioner will not
normally review our handling of a request unless the requester has first
asked us to conduct an internal review.

The Information Commissioner can be contacted through their online webform
at:
[7]https://ico.org.uk/make-a-complaint/foi-...

Or in writing to: Information Commissioner's Office, Wycliffe House, Water
Lane, Wilmslow, Cheshire, SK9 5AF

References

Visible links
1. https://eur01.safelinks.protection.outlo...
2. https://eur01.safelinks.protection.outlo...
3. https://eur01.safelinks.protection.outlo...
4. https://eur01.safelinks.protection.outlo...
5. https://eur01.safelinks.protection.outlo...
6. https://eur01.safelinks.protection.outlo...
7. file:///tmp/http:/about:blank/

FOI Team, Commission on Human Medicines

1 Attachment

Dear Chris Northwood,

I am writing in response to your request for information, received 11th
December.

Please find the response to your request attached.

Yours sincerely,

Safety and Surveillance Group

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 020 3080 6000

[1]gov.uk/mhra

[2]Stay connected

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: [3]MHRA,
[4]CPRD and [5]NIBSC.

References

Visible links
1. https://eur01.safelinks.protection.outlo...
2. https://eur01.safelinks.protection.outlo...
3. https://eur01.safelinks.protection.outlo...
4. https://eur01.safelinks.protection.outlo...
5. https://eur01.safelinks.protection.outlo...